研究单位：[1]Sumitomo Pharma (Suzhou) Co.,Ltd.[2]First Affiliated Hospital of Kunming Medical University Kun Ming,Yunnan,China,650032[3]Beijing Anding Hospital Beijing,Beijing,China,100088[4]Beijing Huilongguan Hospital Beijing,Beijing,China,100096[5]Hebei Province Mental Health Center Baoding,Hebei,China,071000[6]Henan Provincial Mental Hospital Xinxiang,Henan,China,453002[7]The Second Xiangya Hospital of Central South University Changsha,Hunan,China,410000[8]Hunan Province Brain Hospital Changsha,Hunan,China,410007[9]Nanjing Brain Hospital Nanjing,Jiangsu,China,210029[10]Wuxi Mental Health Center Wuxi,Jiangsu,China,214000
研究目的：
A Randomized, Double-blinded, Double-dummy, Parallel-controlled and Multicenter Clinical trial to Investigate Blonanserin in Treatment of Schizophrenia when compared with Risperidone
